Founder, Wilmarth Eye and Laser

Ophthalmology

Dr. Stephen S. Wilmarth, MD


Stephen S. Wilmarth practices Ophthalmology. He studied medicine at Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Doctor Stephen S. Wilmarth, MD is a published physician as well. He has 2 publications published. The latest was: Aspergillus endophthalmitis in an intravenous drug user. He accepts Medicare.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1245240324
NPPES Provider LastName   WILMARTH
NPPES Provider FirstName   STEPHEN
NPPES Provider ZIPCode   95661
NPPES Provider State   CA
Specialty Description   Ophthalmology
Total Claim Count   1802.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1245240324
Last Name Of The Provider WILMARTH
First Name Of The Provider STEPHEN
View All

Similar Doctors


Dr. Brian W. Rothlisberger, MD
This Doctor is OpenDoctor Recommended.
Dr. Richard C. Fentzke, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Sean R. Baker, MD
Dr. Matthew C. Carnahan, MD
This Doctor is OpenDoctor Recommended.
Dr. Kwang S. Kim, MD
Dr. Glenn C. Yiu, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Gary R. Bohlman, MD
Dr. David Telander, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Gabriel Jacob, MD
This Doctor is OpenDoctor Recommended.
Dr. Al L. Brooks, MD
This Doctor is OpenDoctor Recommended.
Dr. Michele S. Todman, MD
This Doctor is OpenDoctor Recommended.
Dr. Michele S. Todman, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog